After Pennsylvania began rewarding Medicaid managed care plans for increasing well-child visits among Black infants, rates did not change significantly overall but varied by region.
|Articles|October 1, 2000
Supplements and Featured Publications
- Optimizing the Management of Gastroesophageal Reflux Disease and its Complications
- Volume 6
- Issue 16 Suppl
Introduction
Advertisement
Articles in this issue
about 26 years ago
Participating Facultyabout 26 years ago
Managed Care Issues in the Treatment of Gastroesophageal Reflux Diseaseabout 26 years ago
Maximizing Outcome of Extraesophageal Reflux Diseaseabout 26 years ago
Changes in the Hypopharynx May Suggest Supraesophageal Reflux Diseaseabout 26 years ago
Diagnosing and Managing Barrett's Esophagusabout 26 years ago
Guidelines for Managing Short-Segment Barrett's Esophagusabout 26 years ago
Total Acid Suppression and Its Effect on Barrett's Esophagusabout 26 years ago
Ablative Therapies for Barrett's Esophagusabout 26 years ago
Selected AbstractsAdvertisement
Related to this article
Greater 340B activity—measured by county-level hospital child sites and contract pharmacy arrangements—was associated with significantly higher county-level total and out-of-pocket health care spending.
The associate editor of Evidence-Based Oncology says the turnover that will follow this week's midterm election calls for renewed engagement from community oncology leaders with members of Congress, due to pressing reimbursement issues.
Medigap Plan F enrollment has declined since it was closed to new beneficiaries in 2020. The percentage of individual Medigap enrollees relative to non–dually eligible traditional Medicare beneficiaries increased from 2013-2024.
Among the therapeutic alternatives used in Medicare’s drug price negotiations, many were generics or biosimilars, and most differed in mechanistic class from the negotiated drug.
Advertisement
Advertisement
Trending on AJMC
1
Hepatitis B Functional Cure Persists Off Treatment After Bepirovirsen
2
Medicaid Cuts and Caregiving in Congress: Andy Kim
3
Health Equity & Access Weekly Roundup: November 6, 2026
4
GLP-1 RAs Improve MASLD, MASH Markers, but Long-Term Benefits Unclear
5